DGAP-Ad-hoc: Fielmann AG / Key word(s): Quarterly / Interim Statement
Our business performance continued to recover in the third quarter of 2020 thanks to the consistent application of our hygiene standards.
According to preliminary estimates, Fielmann generated consolidated sales of approximately € 420 million (previous year: € 400.0 million) and pre-tax profits of around € 80 million (previous year: € 78.5 million) from July to September. Provided that there are no further restrictions due to the coronavirus pandemic in the course of the year, Fielmann will most likely exceed the numbers previously forecast for the full year and expects to generate external sales (incl. VAT) of more than € 1.6 billion (previous year: € 1.76 billion), consolidated sales of more than € 1.4 billion (previous year: € 1.62 billion) and a pre-tax profit of more than € 140 million (previous year: € 253.81 million). We remain confident that we will emerge from this crisis stronger than before.
30-Sep-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Fielmann AG |
Weidetrasse 118a | |
22083 Hamburg | |
Germany | |
Phone: | +49 (0)40 270 76-0 |
Fax: | +49 (0)40 270 76-390 |
Internet: | www.fielmann.de |
ISIN: | DE0005772206 |
WKN: | 577220 |
Indices: | SDAX |
Listed: | Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange |
EQS News ID: | 1137997 |
End of Announcement | DGAP News Service |
|
1137997 30-Sep-2020 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.